Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Talecris Enters Oversold Territory
Yahoo/Zacks.com
Tuesday, November 23, 2010 - 2:15pm
tags:
Talecris
Novartis Must Pay $12M Over Jaw-Bone Damage
Pharmalot
Tuesday, November 23, 2010 - 2:14pm
tags:
settlements, Novartis, Aredia, Zometa, osteoporosis
Dr Reddy to buy Glaxo's US penicillin site
Yahoo/AP
Tuesday, November 23, 2010 - 2:12pm
tags:
GSK, Dr Reddy's, penicillin
Medicis Pharmaceutical: The Trend Continues Lower
Benzinga
Tuesday, November 23, 2010 - 10:52am
tags:
Medicis
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tuesday, November 23, 2010 - 10:49am
tags:
Amgen, M&A, Actelion
Cumberland Pharma Is Flying Under the Radar
Seeking Alpha
Tuesday, November 23, 2010 - 10:48am
tags:
Cumberland, Acetadote
Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Fierce Pharma
Tuesday, November 23, 2010 - 10:40am
tags:
Gilead Sciences, Truvada, HIV
Analyst Recap: Swiss Drugmaker Novartis Has Strong Pipeline
Seeking Alpha
Tuesday, November 23, 2010 - 10:38am
tags:
Novartis, pipelines, emerging markets, R&D
Aoxing Moves Closer to Commercial Production of Narcotic Drug
Seeking Alpha
Tuesday, November 23, 2010 - 10:37am
tags:
Aoxing, narcotics
Vertex Files for Hep C Drug Approval
TheStreet.com
Tuesday, November 23, 2010 - 10:36am
tags:
hepatitis C, Vertex Pharmaceuticals, FDA, Telaprevir
Wockhardt in Talks With Abbott to Sell Nutrition Unit
Bloomberg
Tuesday, November 23, 2010 - 10:35am
tags:
M&A, Wockhardt, Abbott Laboratories, nutrition
Still Hope for Novartis's $125 Million Acquisition of Zhejiang Tianyuan?
Seeking Alpha
Tuesday, November 23, 2010 - 10:23am
tags:
Novartis, M&A, Zhejiang Tianyuan Bio-Pharmaceutical
Teva Gets Boost From Biosimilars
Seeking Alpha
Tuesday, November 23, 2010 - 9:37am
tags:
Teva Pharmaceuticals, biosimilars, Lonza, small molecule drugs
Why Bayer Needs Luck as Much as It Needs Layoffs
BNET Pharma
Tuesday, November 23, 2010 - 9:32am
tags:
Bayer, layoffs, JNJ
Options Action: Johnson & Johnson
CNBC
Tuesday, November 23, 2010 - 9:28am
tags:
JNJ, options
Ariad Gets Good News on Its Endometrial Cancer Drug
Seeking Alpha
Tuesday, November 23, 2010 - 9:27am
tags:
endometrial cancer, Ariad Pharmaceuticals, Merck, mTOR inhibitors, ridaforolimus
J&J Recalls Children's Benadryl, Motrin Over Manufacturing `Deficiencies'
Bloomberg
Tuesday, November 23, 2010 - 9:25am
tags:
recalls, JNJ
Let's Call It a Partial Victory (Merck)
Motley Fool
Tuesday, November 23, 2010 - 8:57am
tags:
Merck, Vytorin, kidney disease
Abbott drug meets goals in kidney disease study
Yahoo/AP
Tuesday, November 23, 2010 - 8:56am
tags:
kidney cancer, Abbott Laboratories, atrasentan
Pfizer's Mixed Bag
Motley Fool
Tuesday, November 23, 2010 - 8:55am
tags:
Pfizer, Apixaban, JNJ, Boehringer Ingelheim, Bristol-Myers Squibb, Axitinib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.